Hostname: page-component-848d4c4894-v5vhk Total loading time: 0 Render date: 2024-06-22T05:14:07.463Z Has data issue: false hasContentIssue false

Spinocerebellar Ataxia Type 12 was not Found in Korean Parkinsonian Patients

Published online by Cambridge University Press:  02 December 2014

Jin Whan Cho
Affiliation:
BK21 NRI and CRI, College of Medicine, Seoul National University, Seoul, South Korea Metropolitan Boramae Hospital, Seoul, South Korea
Sung Yeon Kim
Affiliation:
Department of Laboratory Medicine, Seoul National University, Seoul, South Korea BK21 NRI and CRI, College of Medicine, Seoul National University, Seoul, South Korea Seoul National University Hospital, Seoul, South Korea
Sung Sup Park
Affiliation:
Department of Laboratory Medicine, Seoul National University, Seoul, South Korea BK21 NRI and CRI, College of Medicine, Seoul National University, Seoul, South Korea Seoul National University Hospital, Seoul, South Korea
Beom S. Jeon*
Affiliation:
BK21 NRI and CRI, College of Medicine, Seoul National University, Seoul, South Korea
*
Department of Neurology, Seoul National University College of Medicine, 28 Yeongeon-Dong, Jongno-Gu, Seoul 110-744, South Korea.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Parkinsonism (PD) is occasionally seen in several types of spinocerebellar ataxia (SCA). Mutations in SCA gene have been reported in the patients of parkinsonism without ataxia.

Methods:

We examined spinocerebellar ataxia type 12 mutation in 877 PD and 199 multiple system atrophy (MSA) patients.

Results and Conclusions:

No patients showed abnormal SCA12 expansion. It suggests that PD and MSA are not associated with SCA12 and it is not necessary to screen SCA12 in PD and MSA patients.

Résumé:

RÉSUMÉ:Contexte:

On observe parfois du parkinsonisme dans plusieurs types d’ataxies spinocérébelleuses (SCA). Des mutations du gène de la SCA ont été rapportées chez des patients présentant du parkinsonisme sans ataxie.

Méthodes:

Nous avons recherché ces mutations chez 877 patients parkinsoniens et chez 199 patients atteints d’atrophie multisystémique.

Résultats et conclusions:

Aucun patient n’était porteur d’une expansion anormale du gène de la SCA de type 12. Ceci porte à croire que la maladie de Parkinson et l’atrophie multisystémique ne sont pas associées au gène de la SCA 12 et qu’il n’est pas nécessaire d’en faire le dépistage chez les patients atteints de la maladie de Parkinson et de l’atrophie multisystémique.

Type
Original Articles
Copyright
Copyright © The Canadian Journal of Neurological 2008

References

1. Manto, MU. The wide spectrum of spinocerebellar ataxias (SCAs). Cerebellum. 2005;4:26.CrossRefGoogle ScholarPubMed
2. Gwinn-Hardy, K, Chen, JY, Liu, HC, Liu, TY, Boss, M, Seltzer, W, et al. Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese. Neurology. 2000;55:8005.CrossRefGoogle ScholarPubMed
3. Gwinn-Hardy, K, Singleton, A, O’Suilleabhain, P, Boss, M, Nicholl, D, Adam, A, et al. Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family. Arch Neurol. 2001;58:2969.CrossRefGoogle Scholar
4. Furtado, S, Farrer, M, Tsuboi, Y, Klimek, ML, de la Fuente-Fernández, R, Hussey, J, et al. SCA-2 presenting as parkinsonism in an Alberta family: clinical, genetic, and PET findings. Neurology. 2002;59:16257.CrossRefGoogle Scholar
5. Payami, H, Nutt, J, Gancher, S, Bird, T, McNeal, MG, Seltzer, WK, et al. SCA2 may present as levodopa-responsive parkinsonism. Mov Disord. 2003;18:4259.CrossRefGoogle ScholarPubMed
6. Lu, CS, Wu Chou, YH, Kuo, PC, Chang, HC, Weng, YH. The parkinsonian phenotype of spinocerebellar ataxia type 2. Arch Neurol. 2004;61:358.CrossRefGoogle ScholarPubMed
7. Shan, DE, Liu, RS, Sun, CM, Lee, SJ, Liao, KK, Soong, BW. Presence of spinocerebellar ataxia type 2 gene mutation in a patient with apparently sporadic Parkinson’s disease: clinical implications. Mov Disord. 2004;19:135760.CrossRefGoogle Scholar
8. Wilkins, A, Brown, JM, Barker, RA. SCA2 presenting as levodoparesponsive parkinsonism in a young patient from the United Kingdom: a case report. Mov Disord. 2004;19:5935.CrossRefGoogle Scholar
9. Wu, YR, Lin, HY, Chen, CM, Gwinn-Hardy, K, Ro, LS, Wang, YC, et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson’s disease. Clin Genet. 2004: 65: 209214.CrossRefGoogle ScholarPubMed
10. Simon-Sanchez, J, Hanson, M, Singleton, A, Hernandez, D, McInerney, A, Nussbaum, R, et al. Analysis of SCA-2 and SCA-3 repeats in Parkinsonism: evidence of SCA-2 expansion in a family with autosomal dominant Parkinson’s disease. Neurosci Lett. 2005;382:1914.CrossRefGoogle Scholar
11. Lim, SW, Zhao, Y, Chua, E, Law, HY, Yuen, Y, Pavanni, R, et al. Genetic analysis of SCA2, 3 and 17 in idiopathic Parkinson’s disease. Neurosci Lett. 2006;403:1114.CrossRefGoogle ScholarPubMed
12. Modoni, A, Contarino, MF, Bentivoglio, AR, Tabolacci, E, Santoro, M, Calcagni, ML, et al. Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients. Mov Disord. 2007;22:3247.CrossRefGoogle ScholarPubMed
13. Kim, JM, Hong, S, Kim, GP, Choi, YJ, Kim, YK, Park, SS, et al. Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism. Arch Neurol. 2007;64:15108.CrossRefGoogle ScholarPubMed
14. Holmes, SE, O’Hearn, EE, McInnis, MG, Gorelick-Feldman, DA, Kleiderlein, JJ, Callahan, C, et al. Expansion of a novel CAG trinucleotide repeat in the 5’ region of PPP2R2B is associated with SCA12. Nat Genet. 1999;23:3912.CrossRefGoogle ScholarPubMed
15. Bahl, S, Virdi, K, Mittal, U, Sachdeva, MP, Kalla, AK, Holmes, SE, et al. Evidence of a common founder for SCA12 in the Indian population. Ann Hum Genet. 2005;69:52834.CrossRefGoogle ScholarPubMed
16. Fujigasaki, H, Verma, IC, Camuzat, A, Margolis, RL, Zander, C, Lebre, AS, et al. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol. 2001;49:11721.3.0.CO;2-G>CrossRefGoogle ScholarPubMed
17. Holmes, SE, O’Hearn, E, Margolis, RL. Why is SCA12 different from other SCAs? Cytogenet Genome Res. 2003;100:18997.CrossRefGoogle ScholarPubMed
18. Hughes, AJ, Daniel, SE, Kilford, L, Lees, AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55:1814.CrossRefGoogle ScholarPubMed
19. Gilman, S, Low, PA, Quinn, N, Albanese, A, Ben-Shlomo, Y, Fowler, CJ, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999;163:948.CrossRefGoogle ScholarPubMed
20. Wu, YR, Fung, HC, Lee-Chen, GJ, Gwinn-Hardy, K, Ro, LS, Chen, ST, et al. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases. J Neural Transm. 2005;112:53946 CrossRefGoogle ScholarPubMed